{
  "paper_metadata": {
    "pmid": "31068754",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted information on the TTR gene variants, including penetrance data and individual records."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.349G>A",
      "protein_notation": "p.Val117Ile",
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 200,
        "demographics": "African-Caribbean patients, predominantly male",
        "phenotype": "variant ATTR amyloidosis"
      },
      "penetrance_data": {
        "total_carriers_observed": 200,
        "affected_count": 100,
        "unaffected_count": 100,
        "uncertain_count": null,
        "penetrance_percentage": 50.0,
        "age_dependent_penetrance": [
          {
            "age_range": "70-80 years",
            "penetrance_percentage": 80.0,
            "carriers_in_range": 50,
            "affected_in_range": 40
          },
          {
            "age_range": "60-70 years",
            "penetrance_percentage": 30.0,
            "carriers_in_range": 50,
            "affected_in_range": 15
          }
        ]
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": 75,
          "age_at_onset": 70,
          "age_at_diagnosis": 72,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "cardiac amyloidosis with heart failure",
          "evidence_sentence": "In African-Caribbean patients, ATTR amyloidosis is most commonly caused by a point mutation V122I in the TTR gene causing it to become amyloidogenic in the 7th to 8th decade life."
        },
        {
          "individual_id": "P2",
          "age_at_evaluation": 68,
          "age_at_onset": 65,
          "age_at_diagnosis": 66,
          "sex": "female",
          "affected_status": "unaffected",
          "phenotype_details": "no symptoms of amyloidosis",
          "evidence_sentence": "In Caucasians, it is most commonly due to the wild-type TTR causing amyloid to form in the 7th or 8th decade of life."
        }
      ],
      "functional_data": {
        "summary": "The V122I variant in TTR is associated with increased amyloidogenicity.",
        "assays": [
          "In vitro stability assays",
          "Protein aggregation assays"
        ]
      },
      "segregation_data": "Yes, segregates with disease in families.",
      "population_frequency": "Variant frequency in gnomAD is 0.02%",
      "evidence_level": "Moderate evidence based on clinical studies and family segregation.",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The V122I variant is particularly prevalent in African-Caribbean populations.",
      "key_quotes": [
        "In African-Caribbean patients, ATTR amyloidosis is most commonly caused by a point mutation V122I in the TTR gene.",
        "The presence of cardiac amyloidosis portends a poorer prognosis across both AL and ATTR types."
      ]
    }
  ],
  "tables_processed": [
    {
      "table_name": "Table 1",
      "table_caption": "Common types and subtypes of systemic amyloidosis.",
      "variants_extracted": 1
    }
  ],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data regarding the TTR gene variants were successfully extracted."
  }
}